Experimental device reduces glioblastoma: first human test in the world
A new helmet that generates a non-invasive oscillating magnetic field was able to reduce tumor mass by 31% in a brain cancer patient with glioblastoma.
A new helmet that generates a non-invasive oscillating magnetic field was able to reduce tumor mass by 31% in a brain cancer patient with glioblastoma.
A "lowest common denominator" of all cancers has just been discovered: it can change the fate of many therapies.
A joint study manages to isolate and identify DIRC3, a molecule that suppresses skin cancer. New hopes to stop melanoma.
Detect tumors in two hours, with a single drop of blood and over 99% accuracy? Toshiba has developed a revolutionary method.
New research identifies the mechanism that causes pancreatic cancer to resist chemotherapy. It will lead to better prognosis and treatment.
The device is able to "smell" the surgical smoke produced by the cuts of the electric scalpel, distinguishing the type of tumor and tissue (and helping the neurosurgeon in real time)